The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York BPC 157 & The Gut Brain Axis: A Practitioner's Definitive Review of the Evidence BPC 157 Peptide in Houston BPC 157 Therapy Near Me In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for FDA Moves to Reevaluate Several Peptides American Med Spa Association